Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
215.6 USD | -0.33% | -2.32% | -16.67% |
Mar. 25 | Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell | MT |
Mar. 19 | BIOGEN : Jefferies confirms its Buy rating on the stock | CF |
- Stock
- Equities
- Stock Biogen Inc. - Nasdaq
- News Biogen Inc.